EuroPCR issues statement on bioresorbable stent (BRS) technologies
Ongoing development of bioresorbable stent (BRS) technologies that are bioresorbed after achieving vessel expansion in percutaneous coronary intervention procedures is an important option to optimise outcomes in patients ...
May 22, 2017
0
0